Total Payments
$4,437
2024 Payments
$526.78
Companies
25
Transactions
252
Medicare Patients
6,181
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$4,356 (98.2%)
Education$81.24 (1.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,356 | 250 | 98.2% |
| Education | $81.24 | 2 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $751.32 | 39 | $0 (2024) |
| Merck Sharp & Dohme LLC | $613.94 | 41 | $0 (2024) |
| Astellas Pharma US Inc | $519.15 | 24 | $0 (2024) |
| Gilead Sciences, Inc. | $463.63 | 28 | $0 (2020) |
| Insmed, Inc. | $412.27 | 23 | $0 (2024) |
| ViiV Healthcare Company | $348.46 | 21 | $0 (2024) |
| Theratechnologies Inc. | $223.43 | 13 | $0 (2020) |
| PFIZER INC. | $187.97 | 11 | $0 (2024) |
| TETRAPHASE PHARMACEUTICALS, INC. | $151.51 | 9 | $0 (2020) |
| Cumberland Pharmaceuticals, Inc. | $129.63 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $526.78 | 25 | ABBVIE INC. ($307.69) |
| 2023 | $626.18 | 30 | AbbVie Inc. ($256.93) |
| 2022 | $540.00 | 27 | ABBVIE INC. ($151.51) |
| 2021 | $138.97 | 8 | PFIZER INC. ($48.15) |
| 2020 | $664.69 | 41 | Insmed, Inc. ($194.41) |
| 2019 | $1,374 | 89 | Gilead Sciences, Inc. ($299.97) |
| 2018 | $243.94 | 16 | Merck Sharp & Dohme Corporation ($84.58) |
| 2017 | $321.97 | 16 | Theratechnologies Inc. ($151.10) |
All Payment Transactions
252 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: VACCINES | ||||||
| 12/02/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/04/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $6.36 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/26/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/06/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/15/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: VACCINES | ||||||
| 08/09/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $30.41 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/23/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/15/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/03/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: VACCINES | ||||||
| 06/21/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/06/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $30.45 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/04/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: HIV | ||||||
| 05/07/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/30/2024 | ABBVIE INC. | AVYCAZ (Drug), DALVANCE, TEFLARO | Food and Beverage | In-kind items and services | $30.40 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/05/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/18/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/11/2024 | ABBVIE INC. | AVYCAZ (Drug), DALVANCE, TEFLARO | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/23/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $6.07 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/05/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $33.02 | General |
| Category: Infectious Diseases | ||||||
| 01/31/2024 | ABBVIE INC. | AVYCAZ (Drug), DALVANCE, TEFLARO | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/30/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: HIV | ||||||
| 01/25/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DIFICID | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/05/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $5.45 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,262 | 2,905 | $592,164 | $223,032 |
| 2022 | 5 | 1,361 | 3,023 | $621,819 | $234,421 |
| 2021 | 5 | 1,395 | 3,251 | $666,561 | $259,566 |
| 2020 | 7 | 2,163 | 4,768 | $855,269 | $337,438 |
Total Patients
6,181
Total Services
13,947
Medicare Billing
$1.1M
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 369 | 1,813 | $253,820 | $104,382 | 41.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 560 | 585 | $228,150 | $73,961 | 32.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 182 | 343 | $68,600 | $29,804 | 43.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 98 | 109 | $28,885 | $10,310 | 35.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 14 | 14 | $5,460 | $1,875 | 34.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 17 | 19 | $5,225 | $1,856 | 35.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 22 | 22 | $2,024 | $843.26 | 41.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 666 | 709 | $276,510 | $103,776 | 37.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 450 | 1,959 | $274,260 | $103,733 | 37.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 200 | 309 | $61,800 | $23,476 | 38.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 28 | 29 | $7,685 | $2,801 | 36.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 17 | 17 | $1,564 | $635.99 | 40.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 693 | 755 | $294,450 | $114,809 | 39.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 446 | 2,097 | $293,580 | $113,740 | 38.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 203 | 344 | $68,800 | $27,077 | 39.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 27 | 27 | $7,155 | $2,821 | 39.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 26 | 28 | $2,576 | $1,120 | 43.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 764 | 3,041 | $425,740 | $166,859 | 39.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 908 | 996 | $263,940 | $104,330 | 39.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 276 | 499 | $99,800 | $39,904 | 40.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 130 | 132 | $51,480 | $20,596 | 40.0% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 54 | 54 | $10,600 | $4,266 | 40.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 17 | 31 | $2,329 | $910.62 | 39.1% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 14 | 15 | $1,380 | $572.82 | 41.5% |
About Dr. Michael Threlkeld, M.D
Dr. Michael Threlkeld, M.D is a Infectious Disease healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356318661.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Threlkeld, M.D has received a total of $4,437 in payments from pharmaceutical and medical device companies, with $526.78 received in 2024. These payments were reported across 252 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($4,356).
As a Medicare-enrolled provider, Threlkeld has provided services to 6,181 Medicare beneficiaries, totaling 13,947 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Memphis, TN
- Active Since 03/06/2006
- Last Updated 01/02/2019
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1356318661
Products in Payments
- AVYCAZ (Drug) $724.67
- Arikayce (Drug) $388.08
- Cresemba (Drug) $384.27
- DOVATO (Drug) $289.59
- ISENTRESS (Drug) $223.08
- EGRIFTA (Drug) $196.50
- PREVNAR 20 (Biological) $146.74
- PIFELTRO (Drug) $136.95
- Xerava (Drug) $136.73
- ZERBAXA (Drug) $127.24
- DIFICID (Drug) $95.19
- DALVANCE (Drug) $94.84
- CRESEMBA (Drug) $92.03
- VIBATIV (Drug) $86.39
- Vabomere (Drug) $78.43
- PREZCOBIX (Drug) $65.00
- TRIUMEQ (Drug) $58.87
- TEFLARO (Drug) $46.26
- CUVITRU (Biological) $44.30
- Vibativ (Drug) $43.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Memphis
Dr. Michael Gelfand, Md, MD
Infectious Disease — Payments: $847,459
Infectious Disease $847,459
Dr. Kerry Cleveland, Md, MD
Infectious Disease — Payments: $679,099
Infectious Disease $679,099
Stephen Threlkeld, M.d, M.D
Infectious Disease — Payments: $28,820
Infectious Disease $28,820
Imad Omer, M.d, M.D
Infectious Disease — Payments: $22,171
Infectious Disease $22,171
Margarita Lamothe, M.d, M.D
Infectious Disease — Payments: $13,658
Infectious Disease $13,658
Dr. James Dale, Md, MD
Infectious Disease — Payments: $8,250
Infectious Disease $8,250